Abstract: Bertin et al. partially dispel arguments that pancreas divisum (PD) causes pancreatitis, but fascinatingly indicate that PD associates with CFTR gene mutations predisposing to pancreatitis. This association, however, does not defi nitely confer a pathophysiological role for PD in pancreatitis but may denote that PD co-mingles with CFTR mutations without infl uencing pancreatitis or CFTR mutations infl uence pancreatic duct embryogenesis. We advise " idiopathic pancreatitis " patients with PD to undergo genetic testing. In lieu of CFTR mutations undertake no endoscopic / surgical procedure; if CFTR mutations are found, then refer patients for genetic counseling and withhold endoscopic / surgical therapy unless randomized studies show benefi t. Am J Gastroenterol 2012; 107:318 -320; doi: 10.1038/ajg.2011 Th ere is increasing evidence that pancreas divisum (PD) does not cause pancreatitis. Bertin et al. ( 1 ) add further support that PD does not trigger pancreatitis by showing that the prevalence of PD was similar in patients with and without idiopathic pancreatitis and alcoholic pancreatitis (7, 5, and 7 % , respectively). Although they concluded that PD by itself does not cause pancreatitis, they found that the prevalence of PD in patients with pancreatitis and CFTR , SPINK1, or PRSS1 mutations (a term we use broadly to include polymorphisms) was 47, 16, and 16 % , respectively, and concluded that PD " acts as a partner of genetic mutations " or cofactor in causing pancreatitis in patients with these mutations. Th is second conclusion is problematic. Associations do not confer causation.
Th ere is increasing evidence that pancreas divisum (PD) does not cause pancreatitis. Bertin et al. ( 1 ) add further support that PD does not trigger pancreatitis by showing that the prevalence of PD was similar in patients with and without idiopathic pancreatitis and alcoholic pancreatitis (7, 5 , and 7 % , respectively). Although they concluded that PD by itself does not cause pancreatitis, they found that the prevalence of PD in patients with pancreatitis and CFTR , SPINK1, or PRSS1 mutations (a term we use broadly to include polymorphisms) was 47, 16, and 16 % , respectively, and concluded that PD " acts as a partner of genetic mutations " or cofactor in causing pancreatitis in patients with these mutations. Th is second conclusion is problematic. Associations do not confer causation.
Another analysis of Table 1 of Bertin et al. ( 1 ) , which assumes that all 114 patients with and without gene mutations (fi rst 4 columns) have " idiopathic pancreatitis " , reveals several observations. First, 65 % of patients with " idiopathic pancreatitis " had gene mutations (74 of 114) and 91 % of the subset with PD had a gene mutation (21 of 23). Considering only CFTR mutations, the prevalence of mutations is higher in patients with pancreatitis and PD (61 % ) than in pancreatitis patients without PD (18 % ). Th is latter prevalence data are low, however, compared with the 37 % prevalence of CFTR mutations reported by Cohn et al. ( 2 ) in idiopathic pancreatitis without PD. Although a greater proportion of patients with PD may have a CFTR mutation than patients without PD, these data are insuffi cient to claim that PD is a partner or cofactor with CFTR mutations in causing pancreatitis. Alternative hypotheses that might explain this association are that CFTR mutations associated with pancreatitis also alter embryogenesis of the pancreatic duct and / or PD merely co-mingles with CFTR mutations without infl uencing the genetic susceptibility to pancreatitis.
Not all patients with gene mutations (particularly CFTR and SPINK1 mutations) develop idiopathic recurrent pancreatitis or chronic pancreatitis (AR / CP), and it is unknown what the prevalence of PD is in these persons. Collecting PD prevalence data for persons with gene mutations but no pancreatitis might strengthen or weaken the assertion that PD is a cofactor in causing pancreatitis in patients with gene mutations. If persons with gene mutations and no pancreatitis have a similar prevalence of PD ( ~ 7 % ) as the other control populations, the authors ' assumption would be strengthened. Finding, however, that the prevalence of PD in this group was similar to patients with the gene mutations and pancreatitis would suggest that PD and gene mutations co-mingle without PD being a cofactor in causing AR / CP.
Background prevalence of PD reported by Bertin et al.
( 1 ) corroborates previous fi ndings. For example, there is wide variability reported in the literature for the prevalence of PD in the normal population. Based on a review and pooling of data from 77 studies ( 3 ), we reported 4 -18 % or higher prevalence of PD in patients without pancreatitis. Recent studies report PD prevalence in this range. response. Although there are a myriad of studies to investigate whether these procedures alleviate pancreatitis, none, including a recent systematic review of uncontrolled endoscopic and surgical studies of patients with PD ( 25 ) , are of suffi cient quality to show that either surgical or endoscopic therapy is benefi cial (see recent update ( 24 ) and review ( 3 )).
Th is paper has several important research and clinical implications. First, to understand whether PD participates with genetic cofactors in idiopathic pancreatitis, it is necessary to determine the frequency of PD in the subgroup of patients with CFTR mutations who do not have pancreatitis. Second, patients with " idiopathic pancreatitis " and PD should undergo genetic testing for CFTR mutations. If no gene mutations are found, then no endoscopic or surgical procedure should be undertaken to alter the accessory sphincter. Th ird, if gene mutations are found, then we recommend referring patients for genetic counseling and withholding endoscopic or surgical therapy unless properly designed studies show these therapies benefi t patients. Finding that there possibly is an association between PD and gene mutations (namely CFTR mutations) in causation of pancreatitis aff ords the opportunity to perform randomized studies to determine if accessory sphincter alteration really benefi ts these patients. Genetic data of Bertin et al. ( 1 ) correspond to previous observations, particularly in terms of the association between PD and pancreatitis patients with SPINK1 or PRSS1 gene mutations ( 1 ) . Gene mutations, most commonly CFTR and SPINK1 , associate in up to 50 % of AR / CP patients ( 5 -7 ) . Th e majority of idiopathic AR pancreatitis patients likely have early onset idiopathic CP because CFTR and SPINK1 mutations do not associate with single attacks of acute pancreatitis ( 8, 9 ) and the results of natural history studies of patients with idiopathic AR pancreatitis indicate that most develop CP ( 10 -12 ) . In India, the prevalence of SPINK1 mutations (range 36 -43 % ) is similar in pancreatitis patients with and without PD ( 13 ) . PRSS1 mutations R122H and N291 have a high disease penetrance (80 and 93 % ) ( 14,15 ) and should not be considered as cofactors.
CONFLICT OF INTEREST
Recent results reported by Japanese investigators ( 16 ) diff er from the observations by Bertin et al. ( 1 ) . To reduce biases associated with referral centers, these investigators used diagnostic magnetic resonance cholangiopancreatography in a community setting to detect PD in 46 patients with idiopathic pancreatitis (8 acute, 23 CP, and 15 AR) and in 504 healthy controls. PD prevalence was 2.6 % in the control group and signifi cantly higher in the idiopathic AR / CP groups (33 and 43 % ) but not in the acute pancreatitis group (13 % ). Unfortunately, the investigators did not report genetic data so it is impossible to discern whether there was an association between the increased PD prevalence in the idiopathic AR / CP groups and CFTR mutations. In a future study, these investigators may address this limitation by performing genetic testing.
Cigarette smoking is an etiologic factor that Bertin et al.
( 1 ) overlooked and may have infl uenced their results. Smoking is emerging as major risk for AR pancreatitis and CP ( 17, 18 ) , a proposal dating to Claessen ( 19 ) or earlier. Chronic cigarette smoking impairs CFTR ion channel conductance in pancreatic ductal cells ( 20 ) , one possible mechanism predisposing to idiopathic pancreatitis, particularly in persons carrying a CFTR mutation. Th us, stratifi cation of the data of Bertin et al. ( 1 ) by smoking status may have uncovered whether PD and smoking co-associate or co-mingle in " idiopathic pancreatitis " , similarly to analyses of PD and CFTR mutations in idiopathic pancreatitis. Future studies examining the etiology of idiopathic pancreatitis should consider stratifi cation by cigarette smoking.
Bertin et al. ( 1 ) commented that PD obstructs fl ow of pancreatic juice through the accessory papilla and induces pancreatitis, particularly if there are underlying gene mutations predisposing to pancreatitis. Th is hypothesis is tantalizing, because CFTR mutations increase juice viscosity ( 21 ) . We caution, however, that CFTR and other mutations have additional sensitizing eff ects on the pancreas ( 22, 23 ) , and there is no experimental evidence (to our knowledge) showing that obstruction in the presence of these gene mutations increases susceptibility to pancreatitis. Based on the hypothesis that PD obstructs fl ow of pancreatic juice through the accessory papilla, endoscopic and surgical procedures have been advocated to alleviate this presumed obstruction. As we recently updated ( 24 ) and reviewed ( 3 ), however, there is no standardized method for assessing a functionally signifi cant obstruction of the minor papilla that predicts endoscopic or surgical
